News By Tag
News By Location
Pharma Leader Series With Top 20 Biological Drug Manufacturers
Bharatbook.com come up with a new research report on "Pharma Leader Series: Top 20 Biological Drug Manufacturers 2012-2022" which shows you commercial prospects for leading biopharmaceutical companies.
How are companies in the biological medicines (biologics) industry performing? Visiongain's new report shows you organisations' prospects to 2022. There you find financial data, trends, opportunities and commercial potentials. http://www.bharatbook.com/
We assess 20 leading developers and producers of biological drugs and vaccines - our analyses help you see the future of the biopharma industry and market. See how sales can increase.
In our investigation you discover a biologics revenue forecast for each company, growth rates, rankings and market shares. Also, you see qualitative analyses, news, research and development (R&D) and business outlooks. You receive 113 tables and 80 charts.
Our work lets you assess the most lucrative areas of the biologicals market, especially 20 companies at the forefront of biopharmaceuticals (http://www.bharatbook.com). Their technologies hold great promise.
You can stay ahead in knowledge. The following sections highlight what you find in the report.
The leading company - you find prospects to 2022 for Roche
Roche is the first company our study analyses. See information on its products and activities in 2012, looking ahead.
You find discussions and analysis of its product portfolio:
• Rituxan, • Avastin, • Herceptin, • Lucentis, • Pegasys and other agents.
Also you investigate Roche's R&D pipeline, its commercial challenges from 2012 and a forecast of its biologics revenue to 2022. Next, our report covers many other companies.
You see prospects for leading pharmaceutical biotechs and specialist manufacturers
Our report gives you profiles and analyses for many other companies, including biopharmaceutical specialists such as these:
• Sanofi • Novo Nordisk • Pfizer • GlaxoSmithKline (GSK) • Merck & Co. • Novartis • Amgen • Biogen Idec • CSL Behring • Grifols • Allergan.
You examine product portfolios, breakdowns of sales, R&D pipelines and outlooks, including biologics revenue forecasts to 2022. Our study also covers vaccines. You find analyses of competition, as well as commercial drivers and restraints for those companies and others.
For more information kindly visit : http://www.bharatbook.com/
Contact us at :
Bharat Book Bureau
Ph.: + 91 22 27810772 / 27810773
Fax: + 91 22 27812290
Follow us on twitter: http://twitter.com/#%
Our Blogs : http://bharatbookblog.wordpress.com/